MedTrace Logo

PAF-HEFT (Permanent Atrial Fibrillation in Heart Failure Trial)

NCT00839566 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2025-07-03

No results posted yet for this study

Summary

Examination of CRT efficacy in patients with progressive heart failure and atrial fibrillation at the same time

Conditions

Interventions

PROCEDURE

Ablation

AV-node ablation

OTHER

Rate Control

Rate control by drug

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Christian Perings, MD · marien Hospital Luenen

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2012-03-31
Completion
2012-07-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00839566 on ClinicalTrials.gov